IssueRaiser

If I understand correctly, the hard part safetywise is not making the vaccine, handling it and giving it to the monkeys.

If I understand correctly, the hard part safetywise is not making the vaccine, handling it and giving it to the monkeys. It's the fact that you then have to give the monkeys real Ebola to see if the vaccine worked. So the hard part is handling real Ebola and monkeys infected with it. What these guys have done is broken that real Ebola into two pieces, where one piece is only in the monkeys. So even in the worst case scenario that a monkey infects a human with "real" Ebola when they are testing the vaccine efficiency, the "real" Ebola is now unable to replicate itself in the human body. It's very clever. Edit: so I think the answer by k_sze is wrong, but I'm not sure. Is there an immunologist in the room?

Posted by semi-extrinsic on Mar 27, 2015, 12:22 PM

Tags

Related issues

Raise real-world problems, find people facing the same issue, and discuss solutions.7,500 issues0 comments

reliability (Other)

If I understand correctly, the hard part safetywise is not making the vaccine, handling it and giving it to the monkeys.

semi-extrinsicMar 27, 2015, 12:22 PM

If I understand correctly, the hard part safetywise is not making the vaccine, handling it and giving it to the monkeys. It's the fact that you then have to give the monkeys real Ebola to see if the vaccine worked. So the hard part is handling real Ebola and monkeys infected with it. What these guys have done is broken that real Ebola into two pieces, where one piece is only in the monkeys. So even in the worst case scenario that a monkey infects a human with "real" Ebola when they are testing the vaccine efficiency, the "real" Ebola is now unable to replicate itself in the human body. It's very clever. Edit: so I think the answer by k_sze is wrong, but I'm not sure. Is there an immunologist in the room?

Comments (0)

No comments yet. Start the discussion.

Comment on this issue